,Diagnosis,Treatment code,Diagnosis code,case Specialism code,Diagnosis Treatment Combination ID,Age,Case ID,Activity,Producer code,Section,Specialism code,group,Number of executions,Complete Timestamp,duration,month,weekday,hour,remtime,elapsed,case_length
311,maligniteit cervix,TC3101,DC822,SC7,DTC153637,39.0,1_2,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,30412800.0,0.0,2
312,maligniteit cervix,TC3101,DC822,SC7,DTC153637,39.0,1_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,30412800.0,0.0,2
515,maligniteit ovarium | tuba,TC803,M16,SC7,DTC151957,31.0,4_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,71539200.0,0.0,2
516,maligniteit ovarium | tuba,TC803,M16,SC7,DTC151957,31.0,4_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,71539200.0,0.0,2
609,maligniteit vagina,TC101,M12,SC7,DTC153624,42.0,6_2,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-06 09:00:00,0.0,1.0,3.0,9.0,2246400.0,0.0,2
610,maligniteit vagina,TC101,M12,SC7,DTC153624,42.0,6_2,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-06 09:00:00,0.0,1.0,3.0,9.0,2246400.0,0.0,2
1190,maligniteit vulva,TC603,M11,SC7,DTC154119,59.0,8_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-07 09:00:00,0.0,1.0,4.0,9.0,97891200.0,0.0,2
1191,maligniteit vulva,TC603,M11,SC7,DTC154119,59.0,8_2,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2005-01-07 09:00:00,0.0,1.0,4.0,9.0,97891200.0,0.0,2
2682,Gynaecologische tumoren,TC11,DC106,SC7,DTC376967,30.0,13_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-01-11 09:00:00,0.0,1.0,1.0,9.0,6134400.0,0.0,2
3305,maligniteit vulva,TC101,M11,SC7,other,63.0,19_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,97372800.0,0.0,2
3306,maligniteit vulva,TC101,M11,SC7,other,63.0,19_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,97372800.0,0.0,2
2679,Gynaecologische tumoren,TC11,DC106,SC7,DTC376967,30.0,13_2,AC390520,RATH,Section 5,SC61,Radiotherapy,1.0,2005-01-14 09:00:00,0.0,1.0,4.0,9.0,5875200.0,259200.0,2
3492,maligniteit vulva,TC101,M11,SC7,DTC159154,65.0,21_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-16 09:00:00,0.0,1.0,6.0,9.0,83808000.0,0.0,2
3630,maligniteit cervix,TC61,DC106,SC61,DTC391976,66.0,22_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-17 09:00:00,0.0,1.0,0.0,9.0,7516800.0,0.0,2
3631,maligniteit cervix,TC61,DC106,SC61,DTC391976,66.0,22_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-17 09:00:00,0.0,1.0,0.0,9.0,7516800.0,0.0,2
4181,maligniteit cervix,TC4401,DC822,SC61,DTC172800,40.0,23_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-17 09:00:00,0.0,1.0,0.0,9.0,99878400.0,0.0,2
4182,maligniteit cervix,TC4401,DC822,SC61,DTC172800,40.0,23_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-17 09:00:00,0.0,1.0,0.0,9.0,99878400.0,0.0,2
4747,maligniteit cervix,TC13,DC106,SC61,DTC177238,37.0,24_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,61171200.0,0.0,2
4748,maligniteit cervix,TC13,DC106,SC61,DTC177238,37.0,24_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,61171200.0,0.0,2
3491,maligniteit vulva,TC101,M11,SC7,DTC159154,65.0,21_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-20 09:00:00,5760.0,1.0,3.0,9.0,83462400.0,345600.0,2
5588,maligniteit ovarium | tuba,TC803,DC821,SC7,DTC164424,55.0,30_2,370419S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-24 09:00:00,0.0,1.0,0.0,9.0,99273600.0,0.0,2
5589,maligniteit ovarium | tuba,TC803,DC821,SC7,DTC164424,55.0,30_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-24 09:00:00,0.0,1.0,0.0,9.0,99273600.0,0.0,2
5659,maligniteit cervix,TC101,M13,SC7,other,34.0,31_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-26 09:00:00,0.0,1.0,2.0,9.0,27216000.0,0.0,2
5660,maligniteit cervix,TC101,M13,SC7,other,34.0,31_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-26 09:00:00,0.0,1.0,2.0,9.0,27216000.0,0.0,2
5782,Gynaecologische tumoren,TC101,DC106,SC61,DTC377076,61.0,32_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-01-27 09:00:00,0.0,1.0,3.0,9.0,86400000.0,0.0,2
5783,Gynaecologische tumoren,TC101,DC106,SC61,DTC377076,61.0,32_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-01-27 09:00:00,0.0,1.0,3.0,9.0,86400000.0,0.0,2
6370,maligniteit vulva,TC101,M11,SC7,other,48.0,40_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,93139200.0,0.0,2
6371,maligniteit vulva,TC101,M11,SC7,other,48.0,40_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,93139200.0,0.0,2
7350,maligniteit ovarium | tuba,TC12,DC106,SC61,DTC390809,74.0,47_2,370715S,CRPO,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-07 09:00:00,0.0,2.0,0.0,9.0,16416000.0,0.0,2
7351,maligniteit ovarium | tuba,TC12,DC106,SC61,DTC390809,74.0,47_2,370701S,CRPO,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-07 09:00:00,0.0,2.0,0.0,9.0,16416000.0,0.0,2
7533,Gynaecologische tumoren,TC61,DC106,SC7,DTC350945,35.0,49_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-02-08 09:00:00,0.0,2.0,1.0,9.0,95731200.0,0.0,2
7691,maligniteit cervix,TC603,M13,SC7,DTC174472,54.0,52_2,AC378546,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-02-09 09:00:00,0.0,2.0,2.0,9.0,23068800.0,0.0,2
7692,maligniteit cervix,TC603,M13,SC7,DTC174472,54.0,52_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-02-09 09:00:00,0.0,2.0,2.0,9.0,23068800.0,0.0,2
9073,maligniteit ovarium | tuba,TC101,M16,SC7,DTC207517,71.0,63_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-14 09:00:00,0.0,2.0,0.0,9.0,92620800.0,0.0,2
9384,maligniteit vulva,TC101,M11,SC7,other,58.0,66_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,68256000.0,0.0,2
9394,maligniteit vulva,TC101,M11,SC7,DTC179033,43.0,67_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,96163200.0,0.0,2
9395,maligniteit vulva,TC101,M11,SC7,DTC179033,43.0,67_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,96163200.0,0.0,2
9569,maligniteit vulva,TC101,M11,SC7,DTC179035,68.0,68_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,97200000.0,0.0,2
9705,maligniteit cervix,TC101,M13,SC7,other,45.0,70_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,0.0,0.0,2
9706,maligniteit cervix,TC101,M13,SC7,other,45.0,70_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,0.0,0.0,2
9709,maligniteit ovarium | tuba,TC101,M16,SC7,other,63.0,71_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,39052800.0,0.0,2
9710,maligniteit ovarium | tuba,TC101,M16,SC7,other,63.0,71_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,39052800.0,0.0,2
11060,maligniteit ovarium,TC3101,DC821,SC7,DTC182586,70.0,72_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,33091200.0,0.0,2
11049,maligniteit ovarium,TC3101,DC821,SC7,DTC182586,70.0,72_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-23 09:00:00,0.0,2.0,2.0,9.0,32572800.0,518400.0,2
13229,Gynaecologische tumoren,TC61,DC106,SC7,DTC263802,69.0,78_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-23 09:00:00,0.0,2.0,2.0,9.0,77500800.0,0.0,2
13367,maligniteit endometrium,TC103,M14,SC61,DTC389776,86.0,79_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-23 09:00:00,0.0,2.0,2.0,9.0,13910400.0,0.0,2
13368,maligniteit endometrium,TC103,M14,SC61,DTC389776,86.0,79_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-23 09:00:00,0.0,2.0,2.0,9.0,13910400.0,0.0,2
13540,maligniteit vagina,TC113,M12,SC7,DTC183570,64.0,81_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,9158400.0,0.0,2
13541,maligniteit vagina,TC113,M12,SC7,DTC183570,64.0,81_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,9158400.0,0.0,2
13607,maligniteit vagina,TC101,M12,SC7,DTC185363,74.0,85_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,86659200.0,0.0,2
13608,maligniteit vagina,TC101,M12,SC7,DTC185363,74.0,85_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,86659200.0,0.0,2
15260,maligniteit ovarium | tuba,TC101,M16,SC7,DTC186996,61.0,91_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,73008000.0,0.0,2
15579,maligniteit cervix,TC813,M13,SC7,DTC188021,43.0,93_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-03 09:00:00,0.0,3.0,3.0,9.0,93225600.0,0.0,2
15580,maligniteit cervix,TC813,M13,SC7,DTC188021,43.0,93_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-03 09:00:00,0.0,3.0,3.0,9.0,93225600.0,0.0,2
15611,maligniteit ovarium | tuba,TC101,M16,SC7,DTC187962,57.0,94_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-03 09:00:00,0.0,3.0,3.0,9.0,7257600.0,0.0,2
15612,maligniteit ovarium | tuba,TC101,M16,SC7,DTC187962,57.0,94_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-03 09:00:00,0.0,3.0,3.0,9.0,7257600.0,0.0,2
15906,maligniteit vulva,TC603,M11,SC7,DTC189524,57.0,96_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,80438400.0,0.0,2
15907,maligniteit vulva,TC603,M11,SC7,DTC189524,57.0,96_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,80438400.0,0.0,2
16579,Gynaecologische tumoren,TC13,DC106,SC7,DTC236621,28.0,98_2,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,9417600.0,0.0,2
16580,Gynaecologische tumoren,TC13,DC106,SC7,DTC236621,28.0,98_2,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,9417600.0,0.0,2
17093,maligniteit cervix,TC101,M13,SC7,other,51.0,102_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-09 09:00:00,0.0,3.0,2.0,9.0,47779200.0,0.0,2
17094,maligniteit cervix,TC101,M13,SC7,other,51.0,102_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-09 09:00:00,0.0,3.0,2.0,9.0,47779200.0,0.0,2
17729,maligniteit vulva,TC803,M11,SC7,DTC193870,51.0,110_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,91411200.0,0.0,2
17730,maligniteit vulva,TC803,M11,SC7,DTC193870,51.0,110_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,91411200.0,0.0,2
17814,maligniteit cervix,TC813,M13,SC7,DTC193760,27.0,112_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,91411200.0,0.0,2
17815,maligniteit cervix,TC813,M13,SC7,DTC193760,27.0,112_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,91411200.0,0.0,2
18966,maligniteit cervix,TC101,M13,SC7,DTC343607,41.0,117_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,92620800.0,0.0,2
19021,maligniteit endometrium,TC603,M14,SC7,DTC195713,64.0,118_2,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,14515200.0,0.0,2
19022,maligniteit endometrium,TC603,M14,SC7,DTC195713,64.0,118_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,14515200.0,0.0,2
19864,maligniteit cervix,TC813,M13,SC7,DTC196365,48.0,123_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,88732800.0,0.0,2
19865,maligniteit cervix,TC813,M13,SC7,DTC196365,48.0,123_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,88732800.0,0.0,2
20004,Gynaecologische tumoren,TC61,DC106,SC7,DTC207555,45.0,125_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,89337600.0,0.0,2
20080,maligniteit cervix,TC603,M13,SC7,DTC197882,41.0,126_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-21 09:00:00,0.0,3.0,0.0,9.0,7430400.0,0.0,2
20081,maligniteit cervix,TC603,M13,SC7,DTC197882,41.0,126_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-21 09:00:00,0.0,3.0,0.0,9.0,7430400.0,0.0,2
20320,Gynaecologische tumoren,TC13,DC106,SC61,DTC389827,72.0,128_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,66960000.0,0.0,2
20439,maligniteit ovarium | tuba,TC603,M16,SC7,DTC199520,56.0,130_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,5875200.0,0.0,2
20440,maligniteit ovarium | tuba,TC603,M16,SC7,DTC199520,56.0,130_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,5875200.0,0.0,2
21558,maligniteit ovarium,TC3101,DC821,SC13,DTC210970,70.0,131_2,370489S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,49766400.0,0.0,2
21559,maligniteit ovarium,TC3101,DC821,SC13,DTC210970,70.0,131_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,49766400.0,0.0,2
21915,maligniteit cervix,TC113,M13,SC61,DTC390006,70.0,134_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,59875200.0,0.0,2
21916,maligniteit cervix,TC113,M13,SC61,DTC390006,70.0,134_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,59875200.0,0.0,2
21953,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,135_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,75945600.0,0.0,2
21954,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,135_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,75945600.0,0.0,2
22208,Gynaecologische tumoren,TC13,DC106,SC61,DTC390466,73.0,136_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,58406400.0,0.0,2
22209,Gynaecologische tumoren,TC13,DC106,SC61,DTC390466,73.0,136_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,58406400.0,0.0,2
22257,maligniteit ovarium | tuba,TC101,M16,SC7,DTC200101,24.0,137_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,66528000.0,0.0,2
22258,maligniteit ovarium | tuba,TC101,M16,SC7,DTC200101,24.0,137_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,66528000.0,0.0,2
22898,maligniteit vulva,TC603,M11,SC7,DTC213044,34.0,142_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,85968000.0,0.0,2
23147,maligniteit ovarium | tuba,TC101,M16,SC7,DTC241184,28.0,149_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,70156800.0,0.0,2
23271,maligniteit ovarium | tuba,TC101,M16,SC7,other,75.0,151_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
23272,maligniteit ovarium | tuba,TC101,M16,SC7,other,75.0,151_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,2
23386,maligniteit cervix,TC101,M13,SC7,DTC275638,57.0,153_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-31 09:00:00,0.0,3.0,3.0,9.0,44150400.0,0.0,2
23461,maligniteit vulva,TC101,M11,SC7,DTC256603,60.0,157_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-04 09:00:00,0.0,4.0,0.0,9.0,88992000.0,0.0,2
23480,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,159_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-05 09:00:00,0.0,4.0,1.0,9.0,70243200.0,0.0,2
9069,maligniteit ovarium | tuba,TC101,M16,SC7,DTC207517,71.0,63_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-06 09:00:00,0.0,4.0,2.0,9.0,88214400.0,4406400.0,2
19993,Gynaecologische tumoren,TC61,DC106,SC7,DTC207555,45.0,125_2,370466C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-06 09:00:00,0.0,4.0,2.0,9.0,87609600.0,1728000.0,2
23811,maligniteit vulva,TC503,M11,SC7,DTC206417,82.0,166_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,49507200.0,0.0,2
23852,maligniteit cervix,TC101,DC106,SC7,DTC208202,35.0,168_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,66009600.0,0.0,2
23853,maligniteit cervix,TC101,DC106,SC7,DTC208202,35.0,168_2,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,66009600.0,0.0,2
24222,maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,172_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-12 09:00:00,0.0,4.0,1.0,9.0,50284800.0,0.0,2
22896,maligniteit vulva,TC603,M11,SC7,DTC213044,34.0,142_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-14 09:00:00,0.0,4.0,3.0,9.0,84672000.0,1296000.0,2
24393,maligniteit cervix,TC101,M13,SC7,other,36.0,178_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-14 09:00:00,0.0,4.0,3.0,9.0,34214400.0,0.0,2
24394,maligniteit cervix,TC101,M13,SC7,other,36.0,178_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-14 09:00:00,0.0,4.0,3.0,9.0,34214400.0,0.0,2
24403,maligniteit endometrium,TC101,M14,SC7,other,70.0,179_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-14 09:00:00,0.0,4.0,3.0,9.0,82598400.0,0.0,2
15259,maligniteit ovarium | tuba,TC101,M16,SC7,DTC186996,61.0,91_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-15 09:00:00,63360.0,4.0,4.0,9.0,69206400.0,3801600.0,2
24220,maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,172_2,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2005-04-15 09:00:00,0.0,4.0,4.0,9.0,50025600.0,259200.0,2
24402,maligniteit endometrium,TC101,M14,SC7,other,70.0,179_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-18 09:00:00,5760.0,4.0,0.0,9.0,82252800.0,345600.0,2
24553,maligniteit ovarium | tuba,TC101,M16,SC7,DTC222688,52.0,183_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-18 09:00:00,0.0,4.0,0.0,9.0,90374400.0,0.0,2
24602,maligniteit cervix,TC101,M13,SC7,other,57.0,186_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-20 09:00:00,0.0,4.0,2.0,9.0,65318400.0,0.0,2
25284,Maligne neoplasma ovarium,TC102,DC821,SC13,DTC259650,61.0,190_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-21 09:00:00,0.0,4.0,3.0,9.0,72489600.0,0.0,2
20318,Gynaecologische tumoren,TC13,DC106,SC61,DTC389827,72.0,128_2,AC390003,RATH,Section 5,SC61,Radiotherapy,1.0,2005-04-25 09:00:00,0.0,4.0,0.0,9.0,64108800.0,2851200.0,2
26379,maligniteit vulva,TC101,M11,SC7,other,85.0,196_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,82857600.0,0.0,2
26380,maligniteit vulva,TC101,M11,SC7,other,85.0,196_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,82857600.0,0.0,2
27086,Gynaecologische tumoren,TC61,DC106,SC61,other,76.0,201_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,71798400.0,0.0,2
27087,Gynaecologische tumoren,TC61,DC106,SC61,other,76.0,201_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,71798400.0,0.0,2
24550,maligniteit ovarium | tuba,TC101,M16,SC7,DTC222688,52.0,183_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-28 09:00:00,0.0,4.0,3.0,9.0,89510400.0,864000.0,2
27103,maligniteit vulva,TC101,M11,SC7,other,49.0,203_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-28 09:00:00,0.0,4.0,3.0,9.0,38620800.0,0.0,2
27113,maligniteit vulva,TC101,M11,SC7,other,69.0,205_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-02 09:00:00,0.0,5.0,0.0,9.0,47433600.0,0.0,2
27186,maligniteit endometrium,TC3101,DC823,SC7,DTC247902,48.0,206_2,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-05-02 09:00:00,0.0,5.0,0.0,9.0,81216000.0,0.0,2
27182,maligniteit endometrium,TC3101,DC823,SC7,DTC247902,48.0,206_2,other,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-05-03 09:00:00,0.0,5.0,1.0,9.0,81129600.0,86400.0,2
27917,maligniteit ovarium,TC3101,DC821,SC7,DTC295720,28.0,209_2,370443S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-07 09:00:00,0.0,5.0,5.0,9.0,40262400.0,0.0,2
27918,maligniteit ovarium,TC3101,DC821,SC7,DTC295720,28.0,209_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-07 09:00:00,0.0,5.0,5.0,9.0,40262400.0,0.0,2
28352,maligniteit vulva,TC101,M11,SC7,other,53.0,212_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-10 09:00:00,0.0,5.0,1.0,9.0,75772800.0,0.0,2
28406,maligniteit vulva,TC803,M11,SC7,DTC229783,76.0,213_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,41558400.0,0.0,2
28407,maligniteit vulva,TC803,M11,SC7,DTC229783,76.0,213_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,41558400.0,0.0,2
28446,maligniteit cervix,TC101,M13,SC7,other,44.0,215_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,45360000.0,0.0,2
28447,maligniteit cervix,TC101,M13,SC7,other,44.0,215_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,45360000.0,0.0,2
29023,maligniteit ovarium | tuba,TC101,M16,SC7,other,53.0,219_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,65232000.0,0.0,2
29024,maligniteit ovarium | tuba,TC101,M16,SC7,other,53.0,219_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,65232000.0,0.0,2
29061,maligniteit ovarium | tuba,TC101,M16,SC7,DTC238886,63.0,220_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-13 09:00:00,0.0,5.0,4.0,9.0,79056000.0,0.0,2
7531,Gynaecologische tumoren,TC61,DC106,SC7,DTC350945,35.0,49_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-05-17 09:00:00,0.0,5.0,1.0,9.0,87264000.0,8467200.0,2
29653,maligniteit ovarium,TC3201,DC821,SC7,DTC233544,60.0,228_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,13392000.0,0.0,2
30035,maligniteit vulva,TC503,M11,SC7,DTC236513,86.0,231_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,3715200.0,0.0,2
30036,maligniteit vulva,TC503,M11,SC7,DTC236513,86.0,231_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,3715200.0,0.0,2
30562,maligniteit ovarium,TC803,DC821,SC13,DTC241472,62.0,233_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,79401600.0,0.0,2
30563,maligniteit ovarium,TC803,DC821,SC13,DTC241472,62.0,233_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,79401600.0,0.0,2
9382,maligniteit vulva,TC101,M11,SC7,other,58.0,66_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,59875200.0,8380800.0,2
31435,maligniteit endometrium,TC101,M14,SC7,other,46.0,237_2,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,55123200.0,0.0,2
31488,Gynaecologische tumoren,TC103,DC106,SC61,DTC391195,73.0,238_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,54691200.0,0.0,2
31489,Gynaecologische tumoren,TC103,DC106,SC61,DTC391195,73.0,238_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,54691200.0,0.0,2
29060,maligniteit ovarium | tuba,TC101,M16,SC7,DTC238886,63.0,220_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,18720.0,5.0,3.0,9.0,77932800.0,1123200.0,2
31512,maligniteit vulva,TC101,M11,SC7,other,75.0,240_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,0.0,0.0,2
31513,maligniteit vulva,TC101,M11,SC7,other,75.0,240_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,0.0,0.0,2
32032,maligniteit myometrium,TC101,M15,SC7,DTC247907,46.0,243_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,76723200.0,0.0,2
32162,maligniteit ovarium | tuba,TC603,M16,SC7,DTC239225,19.0,244_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,88732800.0,0.0,2
32163,maligniteit ovarium | tuba,TC603,M16,SC7,DTC239225,19.0,244_2,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,88732800.0,0.0,2
23142,maligniteit ovarium | tuba,TC101,M16,SC7,DTC241184,28.0,149_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,64886400.0,5270400.0,2
23806,maligniteit vulva,TC503,M11,SC7,DTC206417,82.0,166_2,376480A,LAKB,Section 4,SC86,Pharmacy Laboratory,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,44928000.0,4579200.0,2
25279,Maligne neoplasma ovarium,TC102,DC821,SC13,DTC259650,61.0,190_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-30 09:00:00,0.0,5.0,0.0,9.0,69120000.0,3369600.0,2
32978,maligniteit cervix,TC113,M13,SC7,DTC243125,71.0,248_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,22377600.0,0.0,2
32979,maligniteit cervix,TC113,M13,SC7,DTC243125,71.0,248_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,22377600.0,0.0,2
33007,maligniteit cervix,TC101,M13,SC7,DTC243132,87.0,249_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,2
33008,maligniteit cervix,TC101,M13,SC7,DTC243132,87.0,249_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,2
33363,maligniteit cervix,TC101,M13,SC7,other,51.0,252_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-02 09:00:00,0.0,6.0,3.0,9.0,20563200.0,0.0,2
33555,maligniteit vulva,TC101,M11,SC7,DTC245603,55.0,254_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-06 09:00:00,0.0,6.0,0.0,9.0,68947200.0,0.0,2
33556,maligniteit vulva,TC101,M11,SC7,DTC245603,55.0,254_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-06 09:00:00,0.0,6.0,0.0,9.0,68947200.0,0.0,2
33788,maligniteit cervix,TC813,M13,SC7,DTC245809,43.0,255_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-06 09:00:00,0.0,6.0,0.0,9.0,8640000.0,0.0,2
33789,maligniteit cervix,TC813,M13,SC7,DTC245809,43.0,255_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-06 09:00:00,0.0,6.0,0.0,9.0,8640000.0,0.0,2
32030,maligniteit myometrium,TC101,M15,SC7,DTC247907,46.0,243_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,75600000.0,1123200.0,2
34013,Gynaecologische tumoren,TC61,DC106,SC7,other,78.0,258_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,61689600.0,0.0,2
34014,Gynaecologische tumoren,TC61,DC106,SC7,other,78.0,258_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,61689600.0,0.0,2
34229,maligniteit ovarium,TC102,DC821,SC13,DTC255196,51.0,259_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,40521600.0,0.0,2
34312,maligniteit ovarium | tuba,TC101,M16,SC7,DTC247894,42.0,261_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,56073600.0,0.0,2
34313,maligniteit ovarium | tuba,TC101,M16,SC7,DTC247894,42.0,261_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,56073600.0,0.0,2
34379,Gynaecologische tumoren,TC101,DC106,SC61,DTC390450,68.0,265_2,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,87177600.0,0.0,2
34380,Gynaecologische tumoren,TC101,DC106,SC61,DTC390450,68.0,265_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,87177600.0,0.0,2
34228,maligniteit ovarium,TC102,DC821,SC13,DTC255196,51.0,259_2,387042A,SRA6,Section 5,SC62,Radiology,1.0,2005-06-15 09:00:00,10080.0,6.0,2.0,9.0,39916800.0,604800.0,2
34879,Gynaecologische tumoren,TC803,DC106,SC61,DTC390652,54.0,270_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,87091200.0,0.0,2
34880,Gynaecologische tumoren,TC803,DC106,SC61,DTC390652,54.0,270_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,87091200.0,0.0,2
34928,maligniteit ovarium | tuba,TC101,M16,SC7,DTC252273,45.0,272_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,82166400.0,0.0,2
34931,maligniteit vagina,TC101,M12,SC7,DTC253376,65.0,273_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,604800.0,0.0,2
34932,maligniteit vagina,TC101,M12,SC7,DTC253376,65.0,273_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,604800.0,0.0,2
35018,maligniteit cervix,TC101,M13,SC7,DTC279467,39.0,276_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-18 09:00:00,0.0,6.0,5.0,9.0,81475200.0,0.0,2
35027,maligniteit vulva,TC101,M11,SC7,other,82.0,277_2,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-19 09:00:00,0.0,6.0,6.0,9.0,75254400.0,0.0,2
23459,maligniteit vulva,TC101,M11,SC7,DTC256603,60.0,157_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,82166400.0,6825600.0,2
35178,maligniteit cervix,TC101,M13,SC7,other,53.0,281_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,63676800.0,0.0,2
35179,maligniteit cervix,TC101,M13,SC7,other,53.0,281_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,63676800.0,0.0,2
35182,maligniteit cervix,TC101,M13,SC7,other,36.0,282_2,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,4665600.0,0.0,2
35479,maligniteit ovarium | tuba,TC101,M16,SC7,other,56.0,284_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,31276800.0,0.0,2
35480,maligniteit ovarium | tuba,TC101,M16,SC7,other,56.0,284_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,31276800.0,0.0,2
35655,maligniteit ovarium | tuba,TC803,M16,SC7,DTC281336,48.0,286_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-23 09:00:00,0.0,6.0,3.0,9.0,78624000.0,0.0,2
35656,maligniteit ovarium | tuba,TC803,M16,SC7,DTC281336,48.0,286_2,other,SLVE,Section 4,SC86,Special lab radiology,1.0,2005-06-23 09:00:00,0.0,6.0,3.0,9.0,78624000.0,0.0,2
35665,maligniteit vulva,TC101,M11,SC7,other,67.0,287_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-24 09:00:00,0.0,6.0,4.0,9.0,69984000.0,0.0,2
35868,Gynaecologische tumoren,TC61,M14,SC61,DTC390438,67.0,290_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,59961600.0,0.0,2
35869,Gynaecologische tumoren,TC61,M14,SC61,DTC390438,67.0,290_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,59961600.0,0.0,2
35923,Adenoca: corpus uteri st Ic,TC101,M14,SC7,other,69.0,292_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,70761600.0,0.0,2
35924,Adenoca: corpus uteri st Ic,TC101,M14,SC7,other,69.0,292_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,70761600.0,0.0,2
31434,maligniteit endometrium,TC101,M14,SC7,other,46.0,237_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-30 09:00:00,51840.0,6.0,3.0,9.0,52012800.0,3110400.0,2
36077,Gynaecologische tumoren,TC61,DC106,SC7,DTC261957,33.0,295_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-30 09:00:00,0.0,6.0,3.0,9.0,73872000.0,0.0,2
36078,Gynaecologische tumoren,TC61,DC106,SC7,DTC261957,33.0,295_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-30 09:00:00,0.0,6.0,3.0,9.0,73872000.0,0.0,2
13227,Gynaecologische tumoren,TC61,DC106,SC7,DTC263802,69.0,78_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-04 09:00:00,0.0,7.0,0.0,9.0,66182400.0,11318400.0,2
37630,maligniteit cervix,TC101,M13,SC7,DTC266586,46.0,313_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-07 09:00:00,0.0,7.0,3.0,9.0,19353600.0,0.0,2
37631,maligniteit cervix,TC101,M13,SC7,DTC266586,46.0,313_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-07 09:00:00,0.0,7.0,3.0,9.0,19353600.0,0.0,2
24601,maligniteit cervix,TC101,M13,SC7,other,57.0,186_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-10 09:00:00,116640.0,7.0,6.0,9.0,58320000.0,6998400.0,2
37658,maligniteit vulva,TC101,M11,SC7,other,91.0,316_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-11 09:00:00,0.0,7.0,0.0,9.0,70416000.0,0.0,2
38116,maligniteit ovarium | tuba,TC803,M16,SC7,DTC270800,70.0,321_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-13 09:00:00,0.0,7.0,2.0,9.0,1641600.0,0.0,2
38117,maligniteit ovarium | tuba,TC803,M16,SC7,DTC270800,70.0,321_2,375003A,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-13 09:00:00,0.0,7.0,2.0,9.0,1641600.0,0.0,2
38223,maligniteit vulva,TC503,M11,SC7,DTC387193,86.0,323_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-14 09:00:00,0.0,7.0,3.0,9.0,51753600.0,0.0,2
38224,maligniteit vulva,TC503,M11,SC7,DTC387193,86.0,323_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-07-14 09:00:00,0.0,7.0,3.0,9.0,51753600.0,0.0,2
38344,maligniteit cervix,TC603,M13,SC7,DTC272449,45.0,326_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-15 09:00:00,0.0,7.0,4.0,9.0,70416000.0,0.0,2
38345,maligniteit cervix,TC603,M13,SC7,DTC272449,45.0,326_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-07-15 09:00:00,0.0,7.0,4.0,9.0,70416000.0,0.0,2
38643,maligniteit cervix,TC803,M13,SC7,DTC273413,46.0,327_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-15 09:00:00,0.0,7.0,4.0,9.0,78278400.0,0.0,2
38644,maligniteit cervix,TC803,M13,SC7,DTC273413,46.0,327_2,370701S,CITH,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-15 09:00:00,0.0,7.0,4.0,9.0,78278400.0,0.0,2
38831,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC293602,46.0,328_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-18 09:00:00,0.0,7.0,0.0,9.0,42336000.0,0.0,2
38832,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC293602,46.0,328_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-18 09:00:00,0.0,7.0,0.0,9.0,42336000.0,0.0,2
27101,maligniteit vulva,TC101,M11,SC7,other,49.0,203_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-20 09:00:00,0.0,7.0,2.0,9.0,31449600.0,7171200.0,2
23384,maligniteit cervix,TC101,M13,SC7,DTC275638,57.0,153_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,34473600.0,9676800.0,2
40341,maligniteit ovarium | tuba,TC101,M16,SC7,DTC275943,67.0,337_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,7171200.0,0.0,2
40342,maligniteit ovarium | tuba,TC101,M16,SC7,DTC275943,67.0,337_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,7171200.0,0.0,2
34927,maligniteit ovarium | tuba,TC101,M16,SC7,DTC252273,45.0,272_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-24 09:00:00,56160.0,7.0,6.0,9.0,78796800.0,3369600.0,2
40761,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC317614,67.0,339_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-25 09:00:00,0.0,7.0,0.0,9.0,73440000.0,0.0,2
40762,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC317614,67.0,339_2,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2005-07-25 09:00:00,0.0,7.0,0.0,9.0,73440000.0,0.0,2
41201,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC307557,38.0,340_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-25 09:00:00,0.0,7.0,0.0,9.0,61862400.0,0.0,2
41202,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC307557,38.0,340_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-25 09:00:00,0.0,7.0,0.0,9.0,61862400.0,0.0,2
41667,maligniteit ovarium | tuba,TC803,M16,SC7,DTC279291,76.0,342_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-27 09:00:00,0.0,7.0,2.0,9.0,18576000.0,0.0,2
41668,maligniteit ovarium | tuba,TC803,M16,SC7,DTC279291,76.0,342_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-27 09:00:00,0.0,7.0,2.0,9.0,18576000.0,0.0,2
41713,maligniteit ovarium | tuba,TC101,M16,SC7,other,64.0,343_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-27 09:00:00,0.0,7.0,2.0,9.0,4838400.0,0.0,2
41714,maligniteit ovarium | tuba,TC101,M16,SC7,other,64.0,343_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-27 09:00:00,0.0,7.0,2.0,9.0,4838400.0,0.0,2
35016,maligniteit cervix,TC101,M13,SC7,DTC279467,39.0,276_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,78019200.0,3456000.0,2
42050,maligniteit vulva,TC803,M11,SC7,DTC279921,86.0,344_2,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,14601600.0,0.0,2
42051,maligniteit vulva,TC803,M11,SC7,DTC279921,86.0,344_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,14601600.0,0.0,2
42641,maligniteit cervix,TC113,M13,SC7,DTC280007,35.0,347_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,1209600.0,0.0,2
42642,maligniteit cervix,TC113,M13,SC7,DTC280007,35.0,347_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,1209600.0,0.0,2
42649,maligniteit cervix,TC101,M13,SC7,other,87.0,349_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-29 09:00:00,0.0,7.0,4.0,9.0,10108800.0,0.0,2
28350,maligniteit vulva,TC101,M11,SC7,other,53.0,212_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-04 09:00:00,0.0,8.0,3.0,9.0,68342400.0,7430400.0,2
42924,Gynaecologische tumoren,TC13,M13,SC61,DTC390780,42.0,354_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-04 09:00:00,0.0,8.0,3.0,9.0,70070400.0,0.0,2
42925,Gynaecologische tumoren,TC13,M13,SC61,DTC390780,42.0,354_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-04 09:00:00,0.0,8.0,3.0,9.0,70070400.0,0.0,2
42966,maligniteit vulva,TC101,M11,SC7,DTC294837,63.0,355_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-05 09:00:00,0.0,8.0,4.0,9.0,53654400.0,0.0,2
43336,Gynaecologische tumoren,TC61,DC106,SC61,DTC808867,36.0,357_2,AC386902,SRA4,Section 5,SC62,Radiology,1.0,2005-08-05 09:00:00,0.0,8.0,4.0,9.0,63936000.0,0.0,2
35180,maligniteit cervix,TC101,M13,SC7,other,36.0,282_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-15 09:00:00,0.0,8.0,0.0,9.0,0.0,4665600.0,2
44390,Gynaecologische tumoren,TC61,DC106,SC7,other,74.0,369_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-21 09:00:00,0.0,8.0,6.0,9.0,70416000.0,0.0,2
44411,maligniteit vulva,TC101,M11,SC7,DTC368280,50.0,370_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-22 09:00:00,0.0,8.0,0.0,9.0,75772800.0,0.0,2
44412,maligniteit vulva,TC101,M11,SC7,DTC368280,50.0,370_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2005-08-22 09:00:00,0.0,8.0,0.0,9.0,75772800.0,0.0,2
44700,maligniteit cervix,TC101,M13,SC7,DTC294386,35.0,372_2,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,1382400.0,0.0,2
44701,maligniteit cervix,TC101,M13,SC7,DTC294386,35.0,372_2,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,1382400.0,0.0,2
42965,maligniteit vulva,TC101,M11,SC7,DTC294837,63.0,355_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-24 09:00:00,27360.0,8.0,2.0,9.0,52012800.0,1641600.0,2
43335,Gynaecologische tumoren,TC61,DC106,SC61,DTC808867,36.0,357_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-24 09:00:00,27360.0,8.0,2.0,9.0,62294400.0,1641600.0,2
45982,maligniteit cervix,TC813,M13,SC61,DTC355500,53.0,376_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,37929600.0,0.0,2
45983,maligniteit cervix,TC813,M13,SC61,DTC355500,53.0,376_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,37929600.0,0.0,2
47192,Maligne neoplasma cervix uteri,TC3301,DC822,SC7,DTC298954,54.0,378_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-27 09:00:00,0.0,8.0,5.0,9.0,72921600.0,0.0,2
47534,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC312531,53.0,379_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-29 09:00:00,0.0,8.0,0.0,9.0,74649600.0,0.0,2
47535,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC312531,53.0,379_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-29 09:00:00,0.0,8.0,0.0,9.0,74649600.0,0.0,2
23478,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,159_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,57456000.0,12787200.0,2
35663,maligniteit vulva,TC101,M11,SC7,other,67.0,287_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,64108800.0,5875200.0,2
47190,Maligne neoplasma cervix uteri,TC3301,DC822,SC7,DTC298954,54.0,378_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,72576000.0,345600.0,2
47611,Gynaecologische tumoren,TC103,DC106,SC61,DTC390975,51.0,381_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,52704000.0,0.0,2
47612,Gynaecologische tumoren,TC103,DC106,SC61,DTC390975,51.0,381_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,52704000.0,0.0,2
48393,maligniteit cervix,TC3101,DC822,SC13,DTC352318,44.0,386_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-05 09:00:00,0.0,9.0,0.0,9.0,29721600.0,0.0,2
48394,maligniteit cervix,TC3101,DC822,SC13,DTC352318,44.0,386_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-05 09:00:00,0.0,9.0,0.0,9.0,29721600.0,0.0,2
49116,maligniteit cervix,TC101,M13,SC7,other,51.0,389_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-06 09:00:00,0.0,9.0,1.0,9.0,6652800.0,0.0,2
49165,Gynaecologische tumoren,TC61,DC106,SC7,other,49.0,393_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,78624000.0,0.0,2
49166,Gynaecologische tumoren,TC61,DC106,SC7,other,49.0,393_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,78624000.0,0.0,2
49174,Gynaecologische tumoren,TC61,DC106,SC7,other,85.0,394_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,64108800.0,0.0,2
49175,Gynaecologische tumoren,TC61,DC106,SC7,other,85.0,394_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,64108800.0,0.0,2
49641,maligniteit vulva,TC101,M11,SC7,other,73.0,398_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,54950400.0,0.0,2
49642,maligniteit vulva,TC101,M11,SC7,other,73.0,398_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,54950400.0,0.0,2
49857,maligniteit vulva,TC803,M11,SC7,DTC306302,85.0,399_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,14515200.0,0.0,2
49858,maligniteit vulva,TC803,M11,SC7,DTC306302,85.0,399_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,14515200.0,0.0,2
49931,maligniteit vulva,TC503,M11,SC7,DTC306088,59.0,400_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,64108800.0,0.0,2
49932,maligniteit vulva,TC503,M11,SC7,DTC306088,59.0,400_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,64108800.0,0.0,2
49941,maligniteit cervix,TC101,M13,SC7,DTC306035,44.0,401_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,64108800.0,0.0,2
49942,maligniteit cervix,TC101,M13,SC7,DTC306035,44.0,401_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,64108800.0,0.0,2
49952,maligniteit cervix,TC101,M13,SC7,other,43.0,402_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,79056000.0,0.0,2
50436,maligniteit cervix,TC101,M13,SC7,other,70.0,405_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-10 09:00:00,0.0,9.0,5.0,9.0,34300800.0,0.0,2
50451,maligniteit ovarium | tuba,TC101,M16,SC7,DTC353566,71.0,406_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-10 09:00:00,0.0,9.0,5.0,9.0,63936000.0,0.0,2
29628,maligniteit ovarium,TC3201,DC821,SC7,DTC233544,60.0,228_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-13 09:00:00,0.0,9.0,1.0,9.0,3196800.0,10195200.0,2
50462,maligniteit vulva,TC101,M11,SC7,other,76.0,409_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,64713600.0,0.0,2
50463,maligniteit vulva,TC101,M11,SC7,other,76.0,409_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,64713600.0,0.0,2
50594,maligniteit ovarium | tuba,TC803,M16,SC7,DTC310361,65.0,413_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-15 09:00:00,0.0,9.0,3.0,9.0,16070400.0,0.0,2
50595,maligniteit ovarium | tuba,TC803,M16,SC7,DTC310361,65.0,413_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-15 09:00:00,0.0,9.0,3.0,9.0,16070400.0,0.0,2
50671,maligniteit cervix,TC103,M13,SC7,DTC349400,43.0,414_2,370401S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-16 09:00:00,0.0,9.0,4.0,9.0,5356800.0,0.0,2
50672,maligniteit cervix,TC103,M13,SC7,DTC349400,43.0,414_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-16 09:00:00,0.0,9.0,4.0,9.0,5356800.0,0.0,2
50738,maligniteit ovarium | tuba,TC101,M16,SC7,DTC333849,60.0,415_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-16 09:00:00,0.0,9.0,4.0,9.0,60912000.0,0.0,2
50739,maligniteit vulva,TC101,M11,SC7,DTC312551,69.0,416_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-19 09:00:00,0.0,9.0,0.0,9.0,0.0,0.0,2
50740,maligniteit vulva,TC101,M11,SC7,DTC312551,69.0,416_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-19 09:00:00,0.0,9.0,0.0,9.0,0.0,0.0,2
51479,maligniteit ovarium | tuba,TC703,M16,SC7,DTC314265,67.0,422_2,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-09-21 09:00:00,0.0,9.0,2.0,9.0,7257600.0,0.0,2
51480,maligniteit ovarium | tuba,TC703,M16,SC7,DTC314265,67.0,422_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-21 09:00:00,0.0,9.0,2.0,9.0,7257600.0,0.0,2
51510,maligniteit vulva,TC101,M11,SC7,other,80.0,423_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,16848000.0,0.0,2
51511,maligniteit vulva,TC101,M11,SC7,other,80.0,423_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,16848000.0,0.0,2
51518,maligniteit vulva,TC101,M11,SC7,other,81.0,424_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,67651200.0,0.0,2
49950,maligniteit cervix,TC101,M13,SC7,other,43.0,402_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-26 09:00:00,0.0,9.0,0.0,9.0,77500800.0,1555200.0,2
51640,maligniteit ovarium | tuba,TC101,M16,SC7,other,84.0,430_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-26 09:00:00,0.0,9.0,0.0,9.0,70416000.0,0.0,2
50434,maligniteit cervix,TC101,M13,SC7,other,70.0,405_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,32659200.0,1641600.0,2
51983,maligniteit vulva,TC803,M11,SC7,DTC320668,65.0,433_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,68256000.0,0.0,2
51984,maligniteit vulva,TC803,M11,SC7,DTC320668,65.0,433_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,68256000.0,0.0,2
52060,maligniteit endometrium,TC101,M14,SC7,other,61.0,439_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-01 09:00:00,0.0,10.0,5.0,9.0,43891200.0,0.0,2
44388,Gynaecologische tumoren,TC61,DC106,SC7,other,74.0,369_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,66528000.0,3888000.0,2
51516,maligniteit vulva,TC101,M11,SC7,other,81.0,424_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,66528000.0,1123200.0,2
52663,maligniteit cervix,TC503,M13,SC7,DTC324178,35.0,444_2,378619A,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,9849600.0,0.0,2
52664,maligniteit cervix,TC503,M13,SC7,DTC324178,35.0,444_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,9849600.0,0.0,2
52835,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC341092,80.0,446_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-06 09:00:00,0.0,10.0,3.0,9.0,65404800.0,0.0,2
52836,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC341092,80.0,446_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-06 09:00:00,0.0,10.0,3.0,9.0,65404800.0,0.0,2
53259,maligniteit ovarium | tuba,TC101,M16,SC7,DTC373608,80.0,449_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-07 09:00:00,0.0,10.0,4.0,9.0,74131200.0,0.0,2
53686,maligniteit ovarium | tuba,TC3301,DC821,SC13,DTC337908,71.0,453_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-12 09:00:00,0.0,10.0,2.0,9.0,9072000.0,0.0,2
53687,maligniteit ovarium | tuba,TC3301,DC821,SC13,DTC337908,71.0,453_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-12 09:00:00,0.0,10.0,2.0,9.0,9072000.0,0.0,2
49115,maligniteit cervix,TC101,M13,SC7,other,51.0,389_2,AC410500,other,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-13 09:00:00,53280.0,10.0,3.0,9.0,3456000.0,3196800.0,2
54191,maligniteit cervix,TC103,M13,SC61,DTC333256,35.0,457_2,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-10-18 09:00:00,0.0,10.0,1.0,9.0,8035200.0,0.0,2
54192,maligniteit cervix,TC103,M13,SC61,DTC333256,35.0,457_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-10-18 09:00:00,0.0,10.0,1.0,9.0,8035200.0,0.0,2
50736,maligniteit ovarium | tuba,TC101,M16,SC7,DTC333849,60.0,415_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,58060800.0,2851200.0,2
54201,maligniteit vulva,TC101,M11,SC7,other,60.0,458_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,68256000.0,0.0,2
54202,maligniteit vulva,TC101,M11,SC7,other,60.0,458_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,68256000.0,0.0,2
54203,maligniteit vulva,TC101,M11,SC7,other,86.0,459_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
54204,maligniteit vulva,TC101,M11,SC7,other,86.0,459_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,2
54209,maligniteit cervix,TC101,M13,SC7,other,50.0,460_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,47174400.0,0.0,2
54210,maligniteit cervix,TC101,M13,SC7,other,50.0,460_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,47174400.0,0.0,2
54456,maligniteit cervix,TC3101,DC822,SC13,DTC336986,38.0,464_2,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-10-24 09:00:00,0.0,10.0,0.0,9.0,7862400.0,0.0,2
54457,maligniteit cervix,TC3101,DC822,SC13,DTC336986,38.0,464_2,AC410100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-10-24 09:00:00,0.0,10.0,0.0,9.0,7862400.0,0.0,2
54676,maligniteit cervix,TC502,M13,SC7,DTC338649,30.0,467_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,67737600.0,0.0,2
54677,maligniteit cervix,TC502,M13,SC7,DTC338649,30.0,467_2,AC10107,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,67737600.0,0.0,2
55399,Maligne neoplasma cervix uteri,TC61,M13,SC61,DTC347653,59.0,468_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,23068800.0,0.0,2
55400,Maligne neoplasma cervix uteri,TC61,M13,SC61,DTC347653,59.0,468_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,23068800.0,0.0,2
50450,maligniteit ovarium | tuba,TC101,M16,SC7,DTC353566,71.0,406_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,67680.0,10.0,3.0,9.0,59875200.0,4060800.0,2
55539,maligniteit cervix,TC101,M13,SC7,DTC339449,29.0,471_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,74390400.0,0.0,2
55540,maligniteit cervix,TC101,M13,SC7,DTC339449,29.0,471_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,74390400.0,0.0,2
55542,maligniteit cervix,TC101,M13,SC7,other,45.0,472_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,0.0,0.0,2
55543,maligniteit cervix,TC101,M13,SC7,other,45.0,472_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,0.0,0.0,2
55717,maligniteit ovarium | tuba,TC101,M16,SC7,DTC377196,36.0,476_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-28 09:00:00,0.0,10.0,4.0,9.0,66268800.0,0.0,2
27112,maligniteit vulva,TC101,M11,SC7,other,69.0,205_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-29 09:00:00,259200.0,10.0,5.0,9.0,31881600.0,15552000.0,2
56040,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684700,36.0,477_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-31 09:00:00,0.0,10.0,0.0,9.0,71625600.0,0.0,2
56041,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684700,36.0,477_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-31 09:00:00,0.0,10.0,0.0,9.0,71625600.0,0.0,2
56075,maligniteit cervix,TC101,M13,SC7,DTC342888,30.0,478_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-02 09:00:00,0.0,11.0,2.0,9.0,48988800.0,0.0,2
56076,maligniteit cervix,TC101,M13,SC7,DTC342888,30.0,478_2,AC370000,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-11-02 09:00:00,0.0,11.0,2.0,9.0,48988800.0,0.0,2
18947,maligniteit cervix,TC101,M13,SC7,DTC343607,41.0,117_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-03 09:00:00,0.0,11.0,3.0,9.0,72576000.0,20044800.0,2
56313,maligniteit endometrium,TC101,M14,SC7,DTC357172,54.0,482_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-05 09:00:00,0.0,11.0,5.0,9.0,17280000.0,0.0,2
56374,maligniteit vulva,TC101,M11,SC7,other,53.0,486_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,47779200.0,0.0,2
56375,maligniteit vulva,TC101,M11,SC7,other,53.0,486_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,47779200.0,0.0,2
56916,Mucineus adenoca. ovarium st IIIc,TC803,M16,SC7,DTC348215,49.0,492_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,7257600.0,0.0,2
56917,Mucineus adenoca. ovarium st IIIc,TC803,M16,SC7,DTC348215,49.0,492_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,7257600.0,0.0,2
33360,maligniteit cervix,TC101,M13,SC7,other,51.0,252_2,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,6652800.0,13910400.0,2
56970,maligniteit cervix,TC101,M13,SC7,DTC349433,32.0,494_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,24796800.0,0.0,2
56971,maligniteit cervix,TC101,M13,SC7,DTC349433,32.0,494_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,24796800.0,0.0,2
57756,Maligne neoplasma ovarium,TC4401,DC821,SC13,DTC495326,44.0,495_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-11 09:00:00,0.0,11.0,4.0,9.0,62553600.0,0.0,2
58099,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,500_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-16 09:00:00,0.0,11.0,2.0,9.0,64108800.0,0.0,2
58100,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,500_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-16 09:00:00,0.0,11.0,2.0,9.0,64108800.0,0.0,2
56298,maligniteit endometrium,TC101,M14,SC7,DTC357172,54.0,482_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-17 09:00:00,0.0,11.0,3.0,9.0,16243200.0,1036800.0,2
35025,maligniteit vulva,TC101,M11,SC7,other,82.0,277_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-23 09:00:00,0.0,11.0,2.0,9.0,61689600.0,13564800.0,2
42647,maligniteit cervix,TC101,M13,SC7,other,87.0,349_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-23 09:00:00,0.0,11.0,2.0,9.0,0.0,10108800.0,2
52058,maligniteit endometrium,TC101,M14,SC7,other,61.0,439_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-23 09:00:00,0.0,11.0,2.0,9.0,39312000.0,4579200.0,2
57744,Maligne neoplasma ovarium,TC4401,DC821,SC13,DTC495326,44.0,495_2,370419S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-24 09:00:00,0.0,11.0,3.0,9.0,61430400.0,1123200.0,2
58598,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC366424,44.0,507_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-28 09:00:00,0.0,11.0,0.0,9.0,61689600.0,0.0,2
58599,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC366424,44.0,507_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-28 09:00:00,0.0,11.0,0.0,9.0,61689600.0,0.0,2
58909,maligniteit vulva,TC101,M11,SC7,other,65.0,513_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-01 09:00:00,0.0,12.0,3.0,9.0,29030400.0,0.0,2
58910,maligniteit vulva,TC101,M11,SC7,other,65.0,513_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-01 09:00:00,0.0,12.0,3.0,9.0,29030400.0,0.0,2
58942,Gynaecologische tumoren,TC61,DC106,SC7,DTC364462,63.0,515_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-01 09:00:00,0.0,12.0,3.0,9.0,50198400.0,0.0,2
58943,Gynaecologische tumoren,TC61,DC106,SC7,DTC364462,63.0,515_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-01 09:00:00,0.0,12.0,3.0,9.0,50198400.0,0.0,2
58970,maligniteit vulva,TC101,M11,SC7,other,51.0,516_2,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-02 09:00:00,0.0,12.0,4.0,9.0,63849600.0,0.0,2
59865,Maligne neoplasma cervix uteri,TC613,DC822,SC61,DTC386069,53.0,517_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-05 09:00:00,0.0,12.0,0.0,9.0,60048000.0,0.0,2
59866,Maligne neoplasma cervix uteri,TC613,DC822,SC61,DTC386069,53.0,517_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-05 09:00:00,0.0,12.0,0.0,9.0,60048000.0,0.0,2
58969,maligniteit vulva,TC101,M11,SC7,other,51.0,516_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-07 09:00:00,7200.0,12.0,2.0,9.0,63417600.0,432000.0,2
62170,maligniteit ovarium | tuba,TC603,M16,SC7,DTC371732,65.0,522_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-12 09:00:00,0.0,12.0,0.0,9.0,2851200.0,0.0,2
62171,maligniteit ovarium | tuba,TC603,M16,SC7,DTC371732,65.0,522_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-12 09:00:00,0.0,12.0,0.0,9.0,2851200.0,0.0,2
53244,maligniteit ovarium | tuba,TC101,M16,SC7,DTC373608,80.0,449_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,68256000.0,5875200.0,2
62214,maligniteit vagina,TC102,M12,SC7,DTC374377,60.0,524_2,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,0.0,0.0,2
62215,maligniteit vagina,TC102,M12,SC7,DTC374377,60.0,524_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,0.0,0.0,2
55716,maligniteit ovarium | tuba,TC101,M16,SC7,DTC377196,36.0,476_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-19 09:00:00,74880.0,12.0,0.0,9.0,61776000.0,4492800.0,2
63659,maligniteit cervix,TC101,M13,SC7,other,59.0,527_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-19 09:00:00,0.0,12.0,0.0,9.0,68428800.0,0.0,2
63990,maligniteit vulva,TC3101,DC839,SC13,DTC408905,56.0,530_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-21 09:00:00,0.0,12.0,2.0,9.0,17020800.0,0.0,2
66817,Gynaecologische tumoren,TC11,DC106,SC61,DTC408061,61.0,536_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-29 09:00:00,0.0,12.0,3.0,9.0,62380800.0,0.0,2
66818,Gynaecologische tumoren,TC11,DC106,SC61,DTC408061,61.0,536_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-29 09:00:00,0.0,12.0,3.0,9.0,62380800.0,0.0,2
67270,Maligne neoplasma ovarium,TC9101,DC821,SC7,DTC384420,66.0,537_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-29 09:00:00,0.0,12.0,3.0,9.0,68947200.0,0.0,2
67271,Maligne neoplasma ovarium,TC9101,DC821,SC7,DTC384420,66.0,537_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-29 09:00:00,0.0,12.0,3.0,9.0,68947200.0,0.0,2
68038,maligniteit cervix,other,M13,SC7,other,45.0,542_2,AC410100,SGIC,Section 2,SC7,Nursing ward,1.0,2006-01-03 09:00:00,0.0,1.0,1.0,9.0,12182400.0,0.0,2
68039,maligniteit cervix,other,M13,SC7,other,45.0,542_2,AC419100,SGIC,Section 2,SC7,Nursing ward,1.0,2006-01-03 09:00:00,0.0,1.0,1.0,9.0,12182400.0,0.0,2
70463,Gynaecologische tumoren,TC101,DC106,SC61,DTC575083,59.0,551_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,67219200.0,0.0,2
70464,Gynaecologische tumoren,TC101,DC106,SC61,DTC575083,59.0,551_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,67219200.0,0.0,2
9567,maligniteit vulva,TC101,M11,SC7,DTC179035,68.0,68_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,68774400.0,28425600.0,2
63988,maligniteit vulva,TC3101,DC839,SC13,DTC408905,56.0,530_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,15120000.0,1900800.0,2
70640,maligniteit ovarium | tuba,TC3101,DC821,SC13,DTC582597,40.0,554_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,23932800.0,0.0,2
70656,maligniteit ovarium | tuba,TC101,M16,SC7,other,48.0,556_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,36288000.0,0.0,2
70657,maligniteit ovarium | tuba,TC101,M16,SC7,other,48.0,556_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,36288000.0,0.0,2
37656,maligniteit vulva,TC101,M11,SC7,other,91.0,316_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-16 09:00:00,0.0,1.0,0.0,9.0,54086400.0,16329600.0,2
71915,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC416207,44.0,562_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,64713600.0,0.0,2
71916,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC416207,44.0,562_2,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,64713600.0,0.0,2
71960,maligniteit cervix,TC61,DC106,SC61,DTC841377,50.0,563_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,33177600.0,0.0,2
71961,maligniteit cervix,TC61,DC106,SC61,DTC841377,50.0,563_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,33177600.0,0.0,2
72194,maligniteit cervix,TC101,M13,SC7,other,61.0,566_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,50803200.0,0.0,2
72216,maligniteit endometrium,TC101,M14,SC7,DTC399888,48.0,569_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,66528000.0,0.0,2
72217,maligniteit endometrium,TC101,M14,SC7,DTC399888,48.0,569_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,66528000.0,0.0,2
72738,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC626861,36.0,571_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-25 09:00:00,0.0,1.0,2.0,9.0,47174400.0,0.0,2
72739,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC626861,36.0,571_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-25 09:00:00,0.0,1.0,2.0,9.0,47174400.0,0.0,2
51639,maligniteit ovarium | tuba,TC101,M16,SC7,other,84.0,430_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-30 09:00:00,181440.0,1.0,0.0,9.0,59529600.0,10886400.0,2
73875,Maligne neoplasma ovarium,TC803,DC821,SC13,DTC468383,43.0,582_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-31 09:00:00,0.0,1.0,1.0,9.0,67132800.0,0.0,2
73876,Maligne neoplasma ovarium,TC803,DC821,SC13,DTC468383,43.0,582_2,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-31 09:00:00,0.0,1.0,1.0,9.0,67132800.0,0.0,2
74178,Maligne neoplasma ovarium,TC803,DC821,SC61,DTC622045,56.0,585_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,66441600.0,0.0,2
74179,Maligne neoplasma ovarium,TC803,DC821,SC61,DTC622045,56.0,585_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,66441600.0,0.0,2
74421,maligniteit vulva,TC101,M11,SC7,other,58.0,588_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,16329600.0,0.0,2
74422,maligniteit vulva,TC101,M11,SC7,other,58.0,588_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,16329600.0,0.0,2
74427,maligniteit cervix,TC101,M13,SC7,other,44.0,589_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,64800000.0,0.0,2
74428,maligniteit cervix,TC101,M13,SC7,other,44.0,589_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,64800000.0,0.0,2
75035,Maligne neoplasma cervix uteri,TC3301,DC822,SC61,DTC429774,38.0,591_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,66614400.0,0.0,2
75036,Maligne neoplasma cervix uteri,TC3301,DC822,SC61,DTC429774,38.0,591_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,66614400.0,0.0,2
75315,Plaveiselcelcarcinoom cervix (nno),TC103,M13,SC7,DTC413918,36.0,594_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-09 09:00:00,0.0,2.0,3.0,9.0,65750400.0,0.0,2
75316,Plaveiselcelcarcinoom cervix (nno),TC103,M13,SC7,DTC413918,36.0,594_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-09 09:00:00,0.0,2.0,3.0,9.0,65750400.0,0.0,2
75636,Gynaecologische tumoren,TC62,DC106,SC61,DTC841442,46.0,595_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-02-09 09:00:00,0.0,2.0,3.0,9.0,65318400.0,0.0,2
75637,Gynaecologische tumoren,TC62,DC106,SC61,DTC841442,46.0,595_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-02-09 09:00:00,0.0,2.0,3.0,9.0,65318400.0,0.0,2
76187,maligniteit vulva,TC101,M11,SC7,DTC418025,28.0,598_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,10713600.0,0.0,2
76188,maligniteit vulva,TC101,M11,SC7,DTC418025,28.0,598_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,10713600.0,0.0,2
76229,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC418173,61.0,599_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,64713600.0,0.0,2
76230,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC418173,61.0,599_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,64713600.0,0.0,2
76315,maligniteit vulva,TC101,M11,SC7,other,92.0,604_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,0.0,0.0,2
76316,maligniteit vulva,TC101,M11,SC7,other,92.0,604_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,0.0,0.0,2
76563,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC448179,29.0,606_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,55382400.0,0.0,2
76564,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC448179,29.0,606_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,55382400.0,0.0,2
76941,maligniteit vulva,TC101,M11,SC7,DTC426794,86.0,616_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-01 09:00:00,0.0,3.0,2.0,9.0,56764800.0,0.0,2
76942,maligniteit vulva,TC101,M11,SC7,DTC426794,86.0,616_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-01 09:00:00,0.0,3.0,2.0,9.0,56764800.0,0.0,2
77204,maligniteit cervix,TC803,M13,SC7,DTC429785,41.0,619_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-06 09:00:00,0.0,3.0,0.0,9.0,29894400.0,0.0,2
77205,maligniteit cervix,TC803,M13,SC7,DTC429785,41.0,619_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-06 09:00:00,0.0,3.0,0.0,9.0,29894400.0,0.0,2
77625,maligniteit ovarium | tuba,TC101,M16,SC7,other,40.0,621_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-03-06 09:00:00,0.0,3.0,0.0,9.0,0.0,0.0,2
77626,maligniteit ovarium | tuba,TC101,M16,SC7,other,40.0,621_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-06 09:00:00,0.0,3.0,0.0,9.0,0.0,0.0,2
78090,maligniteit cervix,TC101,M13,SC7,DTC430507,46.0,623_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-07 09:00:00,0.0,3.0,1.0,9.0,33868800.0,0.0,2
78091,maligniteit cervix,TC101,M13,SC7,DTC430507,46.0,623_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-03-07 09:00:00,0.0,3.0,1.0,9.0,33868800.0,0.0,2
79329,Maligne neoplasma cervix uteri,TC9102,DC822,SC61,DTC438991,49.0,625_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-08 09:00:00,0.0,3.0,2.0,9.0,56678400.0,0.0,2
79330,Maligne neoplasma cervix uteri,TC9102,DC822,SC61,DTC438991,49.0,625_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-08 09:00:00,0.0,3.0,2.0,9.0,56678400.0,0.0,2
79955,Maligne neoplasma cervix uteri,TC3301,M13,SC61,DTC435615,31.0,629_2,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-09 09:00:00,0.0,3.0,3.0,9.0,16329600.0,0.0,2
79956,Maligne neoplasma cervix uteri,TC3301,M13,SC61,DTC435615,31.0,629_2,AC370701,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-09 09:00:00,0.0,3.0,3.0,9.0,16329600.0,0.0,2
79987,Gynaecologische tumoren,TC61,DC106,SC7,DTC432315,69.0,630_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-09 09:00:00,0.0,3.0,3.0,9.0,50803200.0,0.0,2
79988,Gynaecologische tumoren,TC61,DC106,SC7,DTC432315,69.0,630_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-09 09:00:00,0.0,3.0,3.0,9.0,50803200.0,0.0,2
80532,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC448136,71.0,632_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,58320000.0,0.0,2
80533,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC448136,71.0,632_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,58320000.0,0.0,2
80569,maligniteit endometrium,TC101,M14,SC7,other,65.0,633_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,33955200.0,0.0,2
80570,maligniteit endometrium,TC101,M14,SC7,other,65.0,633_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,33955200.0,0.0,2
80595,maligniteit endometrium,TC101,M14,SC7,DTC434242,43.0,634_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,62553600.0,0.0,2
80945,maligniteit vulva,TC101,M11,SC7,other,59.0,638_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,52617600.0,0.0,2
80946,maligniteit vulva,TC101,M11,SC7,other,59.0,638_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,52617600.0,0.0,2
80971,maligniteit cervix,TC61,DC106,SC61,other,34.0,640_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,16416000.0,0.0,2
81917,maligniteit myometrium,TC603,M15,SC7,DTC440344,74.0,644_2,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-17 09:00:00,0.0,3.0,4.0,9.0,1641600.0,0.0,2
81918,maligniteit myometrium,TC603,M15,SC7,DTC440344,74.0,644_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-17 09:00:00,0.0,3.0,4.0,9.0,1641600.0,0.0,2
82034,maligniteit endometrium,TC101,M14,SC7,other,46.0,646_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-20 09:00:00,0.0,3.0,0.0,9.0,34646400.0,0.0,2
82035,maligniteit endometrium,TC101,M14,SC7,other,46.0,646_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-20 09:00:00,0.0,3.0,0.0,9.0,34646400.0,0.0,2
82197,Adenoca: corpus uteri st IIIa,TC803,M14,SC7,DTC440930,73.0,651_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,61862400.0,0.0,2
82198,Adenoca: corpus uteri st IIIa,TC803,M14,SC7,DTC440930,73.0,651_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,61862400.0,0.0,2
82680,Gynaecologische tumoren,TC101,DC106,SC61,DTC803570,69.0,658_2,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-03-29 09:00:00,0.0,3.0,2.0,9.0,51235200.0,0.0,2
82681,Gynaecologische tumoren,TC101,DC106,SC61,DTC803570,69.0,658_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-03-29 09:00:00,0.0,3.0,2.0,9.0,51235200.0,0.0,2
82841,maligniteit ovarium | tuba,TC101,M16,SC7,DTC446336,47.0,662_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-30 09:00:00,0.0,3.0,3.0,9.0,5356800.0,0.0,2
82842,maligniteit ovarium | tuba,TC101,M16,SC7,DTC446336,47.0,662_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-30 09:00:00,0.0,3.0,3.0,9.0,5356800.0,0.0,2
83427,Gynaecologische tumoren,TC13,DC106,SC61,DTC574951,38.0,667_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,52531200.0,0.0,2
83428,Gynaecologische tumoren,TC13,DC106,SC61,DTC574951,38.0,667_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,52531200.0,0.0,2
84450,Plav.celcarc. vulva: st III1,TC613,M11,SC7,DTC455793,89.0,673_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,14515200.0,0.0,2
84451,Plav.celcarc. vulva: st III1,TC613,M11,SC7,DTC455793,89.0,673_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,14515200.0,0.0,2
84454,maligniteit cervix,TC101,M13,SC7,other,50.0,674_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,30931200.0,0.0,2
84455,maligniteit cervix,TC101,M13,SC7,other,50.0,674_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,30931200.0,0.0,2
84734,Maligne neoplasma cervix uteri,TC3101,DC822,SC7,DTC455470,44.0,675_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,8380800.0,0.0,2
84735,Maligne neoplasma cervix uteri,TC3101,DC822,SC7,DTC455470,44.0,675_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,8380800.0,0.0,2
85549,maligniteit endometrium,TC101,M14,SC7,other,59.0,679_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-13 09:00:00,0.0,4.0,3.0,9.0,52012800.0,0.0,2
85550,maligniteit endometrium,TC101,M14,SC7,other,59.0,679_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-13 09:00:00,0.0,4.0,3.0,9.0,52012800.0,0.0,2
85810,Sereus adenoca: ovarium st IIIc,TC603,M16,SC7,DTC458491,63.0,681_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-18 09:00:00,0.0,4.0,1.0,9.0,7344000.0,0.0,2
85811,Sereus adenoca: ovarium st IIIc,TC603,M16,SC7,DTC458491,63.0,681_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-18 09:00:00,0.0,4.0,1.0,9.0,7344000.0,0.0,2
85952,maligniteit cervix,TC803,M13,SC7,DTC459519,36.0,683_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,8294400.0,0.0,2
85953,maligniteit cervix,TC803,M13,SC7,DTC459519,36.0,683_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,8294400.0,0.0,2
86204,maligniteit endometrium,TC101,M14,SC7,other,62.0,686_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,1296000.0,0.0,2
86205,maligniteit endometrium,TC101,M14,SC7,other,62.0,686_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,1296000.0,0.0,2
70638,maligniteit ovarium | tuba,TC3101,DC821,SC13,DTC582597,40.0,554_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-24 09:00:00,0.0,4.0,0.0,9.0,15120000.0,8812800.0,2
86708,Gynaecologische tumoren,TC13,DC106,SC7,DTC469372,71.0,692_2,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-03 09:00:00,0.0,5.0,2.0,9.0,57110400.0,0.0,2
86709,Gynaecologische tumoren,TC13,DC106,SC7,DTC469372,71.0,692_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-03 09:00:00,0.0,5.0,2.0,9.0,57110400.0,0.0,2
87115,Maligne nieuwv. cervix uteri (ov),TC61,DC106,SC61,DTC803593,58.0,697_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,57456000.0,0.0,2
87116,Maligne nieuwv. cervix uteri (ov),TC61,DC106,SC61,DTC803593,58.0,697_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,57456000.0,0.0,2
87136,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,DTC472041,39.0,698_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,8467200.0,0.0,2
87137,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,DTC472041,39.0,698_2,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,8467200.0,0.0,2
87168,maligniteit myometrium,TC101,M15,SC7,other,43.0,699_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,3196800.0,0.0,2
87169,maligniteit myometrium,TC101,M15,SC7,other,43.0,699_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,3196800.0,0.0,2
87252,maligniteit endometrium,TC101,M14,SC7,DTC473664,51.0,702_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,6134400.0,0.0,2
87253,maligniteit endometrium,TC101,M14,SC7,DTC473664,51.0,702_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,6134400.0,0.0,2
87261,Sereus adenoca: ovarium st IIIc,TC104,M16,SC7,DTC473952,63.0,703_2,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
87262,Sereus adenoca: ovarium st IIIc,TC104,M16,SC7,DTC473952,63.0,703_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
87445,"Plaveiselcelca, cervix st IIIb",TC113,M13,SC7,DTC474860,80.0,704_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-11 09:00:00,0.0,5.0,3.0,9.0,2332800.0,0.0,2
87446,"Plaveiselcelca, cervix st IIIb",TC113,M13,SC7,DTC474860,80.0,704_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-11 09:00:00,0.0,5.0,3.0,9.0,2332800.0,0.0,2
87478,maligniteit cervix,TC101,M13,SC7,other,57.0,706_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-15 09:00:00,0.0,5.0,0.0,9.0,0.0,0.0,2
87479,maligniteit cervix,TC101,M13,SC7,other,57.0,706_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-15 09:00:00,0.0,5.0,0.0,9.0,0.0,0.0,2
87508,maligniteit endometrium,TC13,DC106,SC61,DTC575182,72.0,707_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-15 09:00:00,0.0,5.0,0.0,9.0,2505600.0,0.0,2
87509,maligniteit endometrium,TC13,DC106,SC61,DTC575182,72.0,707_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-15 09:00:00,0.0,5.0,0.0,9.0,2505600.0,0.0,2
87702,maligniteit ovarium | tuba,TC101,M16,SC7,DTC477548,27.0,709_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-16 09:00:00,0.0,5.0,1.0,9.0,52012800.0,0.0,2
87703,maligniteit ovarium | tuba,TC101,M16,SC7,DTC477548,27.0,709_2,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-16 09:00:00,0.0,5.0,1.0,9.0,52012800.0,0.0,2
88209,Adenoca: corpus uteri st IVb,TC3103,DC823,SC13,DTC496853,76.0,713_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,2419200.0,0.0,2
88210,Adenoca: corpus uteri st IVb,TC3103,DC823,SC13,DTC496853,76.0,713_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,2419200.0,0.0,2
88273,other,TC101,M16,SC7,other,39.0,715_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,21772800.0,0.0,2
88547,maligniteit vulva,TC101,M11,SC7,other,80.0,719_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
88548,maligniteit vulva,TC101,M11,SC7,other,80.0,719_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,2
88738,Metastasen maligniteit ovarium (nno),TC101,M16,SC7,DTC484397,75.0,721_2,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,518400.0,0.0,2
88739,Metastasen maligniteit ovarium (nno),TC101,M16,SC7,DTC484397,75.0,721_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,518400.0,0.0,2
88272,other,TC101,M16,SC7,other,39.0,715_2,AC387070,SRA4,Section 5,SC62,Radiology,1.0,2006-06-01 09:00:00,20160.0,6.0,3.0,9.0,20563200.0,1209600.0,2
89938,Sereus adenoca: ovarium st IV,TC803,M16,SC7,DTC489159,44.0,725_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-01 09:00:00,0.0,6.0,3.0,9.0,28339200.0,0.0,2
89939,Sereus adenoca: ovarium st IV,TC803,M16,SC7,DTC489159,44.0,725_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-01 09:00:00,0.0,6.0,3.0,9.0,28339200.0,0.0,2
90312,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-08 09:00:00,0.0,6.0,3.0,9.0,48384000.0,0.0,2
90313,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730_2,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-08 09:00:00,0.0,6.0,3.0,9.0,48384000.0,0.0,2
90394,Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-08 09:00:00,0.0,6.0,3.0,9.0,0.0,0.0,2
90395,Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733_2,370715A,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-08 09:00:00,0.0,6.0,3.0,9.0,0.0,0.0,2
91027,Plaveiselcelcarcinoom cervix (nno),TC104,M13,SC7,other,37.0,737_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-12 09:00:00,0.0,6.0,0.0,9.0,0.0,0.0,2
91028,Plaveiselcelcarcinoom cervix (nno),TC104,M13,SC7,other,37.0,737_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-12 09:00:00,0.0,6.0,0.0,9.0,0.0,0.0,2
91964,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-14 09:00:00,0.0,6.0,2.0,9.0,40953600.0,0.0,2
91965,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-14 09:00:00,0.0,6.0,2.0,9.0,40953600.0,0.0,2
92774,Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-16 09:00:00,0.0,6.0,4.0,9.0,29721600.0,0.0,2
92775,Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-16 09:00:00,0.0,6.0,4.0,9.0,29721600.0,0.0,2
93372,Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745_2,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,55036800.0,0.0,2
93373,Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,55036800.0,0.0,2
94013,Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746_2,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,52617600.0,0.0,2
94014,Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746_2,AC370424,CITC,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,52617600.0,0.0,2
63658,maligniteit cervix,TC101,M13,SC7,other,59.0,527_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 09:00:00,264960.0,6.0,2.0,9.0,52531200.0,15897600.0,2
94057,maligniteit ovarium | tuba,TC101,M16,SC7,other,72.0,747_2,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 09:00:00,0.0,6.0,2.0,9.0,691200.0,0.0,2
94188,Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-22 09:00:00,0.0,6.0,3.0,9.0,26697600.0,0.0,2
94189,Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-22 09:00:00,0.0,6.0,3.0,9.0,26697600.0,0.0,2
94472,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 09:00:00,0.0,6.0,2.0,9.0,10800000.0,0.0,2
94473,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 09:00:00,0.0,6.0,2.0,9.0,10800000.0,0.0,2
94055,maligniteit ovarium | tuba,TC101,M16,SC7,other,72.0,747_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-29 09:00:00,0.0,6.0,3.0,9.0,0.0,691200.0,2
94593,Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759_2,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-03 09:00:00,0.0,7.0,0.0,9.0,27993600.0,0.0,2
94594,Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-07-03 09:00:00,0.0,7.0,0.0,9.0,27993600.0,0.0,2
95065,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,51494400.0,0.0,2
95066,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,51494400.0,0.0,2
95192,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,7084800.0,0.0,2
95193,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,7084800.0,0.0,2
95368,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-07 09:00:00,0.0,7.0,4.0,9.0,52531200.0,0.0,2
95369,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-07 09:00:00,0.0,7.0,4.0,9.0,52531200.0,0.0,2
95454,maligniteit cervix,TC101,M13,SC7,other,41.0,769_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,30844800.0,0.0,2
95730,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-14 09:00:00,0.0,7.0,4.0,9.0,52444800.0,0.0,2
95731,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-14 09:00:00,0.0,7.0,4.0,9.0,52444800.0,0.0,2
95791,Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 09:00:00,0.0,7.0,0.0,9.0,51062400.0,0.0,2
95792,Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 09:00:00,0.0,7.0,0.0,9.0,51062400.0,0.0,2
95819,maligniteit vulva,TC101,M11,SC7,other,80.0,774_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,2
95820,maligniteit vulva,TC101,M11,SC7,other,80.0,774_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,2
80593,maligniteit endometrium,TC101,M14,SC7,DTC434242,43.0,634_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-27 09:00:00,0.0,7.0,3.0,9.0,50803200.0,11750400.0,2
96532,Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,40.0,786_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-27 09:00:00,0.0,7.0,3.0,9.0,604800.0,0.0,2
96533,Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,40.0,786_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-27 09:00:00,0.0,7.0,3.0,9.0,604800.0,0.0,2
96891,other,TC101,M15,SC7,other,78.0,790_2,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-08-02 09:00:00,0.0,8.0,2.0,9.0,86400.0,0.0,2
96892,other,TC101,M15,SC7,other,78.0,790_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-08-02 09:00:00,0.0,8.0,2.0,9.0,86400.0,0.0,2
97096,Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 09:00:00,0.0,8.0,4.0,9.0,12268800.0,0.0,2
97097,Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 09:00:00,0.0,8.0,4.0,9.0,12268800.0,0.0,2
97182,Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793_2,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-07 09:00:00,0.0,8.0,0.0,9.0,48470400.0,0.0,2
97183,Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-07 09:00:00,0.0,8.0,0.0,9.0,48470400.0,0.0,2
97304,Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795_2,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-10 09:00:00,0.0,8.0,3.0,9.0,32572800.0,0.0,2
97305,Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795_2,AC355409,LVPT,Section 4,SC88,Pathology,1.0,2006-08-10 09:00:00,0.0,8.0,3.0,9.0,32572800.0,0.0,2
98390,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,61.0,798_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-17 09:00:00,0.0,8.0,3.0,9.0,604800.0,0.0,2
98391,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,61.0,798_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-17 09:00:00,0.0,8.0,3.0,9.0,604800.0,0.0,2
100451,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-24 09:00:00,0.0,8.0,3.0,9.0,38620800.0,0.0,2
100452,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-24 09:00:00,0.0,8.0,3.0,9.0,38620800.0,0.0,2
100485,maligniteit cervix,TC101,M13,SC7,other,40.0,806_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-28 09:00:00,0.0,8.0,0.0,9.0,0.0,0.0,2
100486,maligniteit cervix,TC101,M13,SC7,other,40.0,806_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-28 09:00:00,0.0,8.0,0.0,9.0,0.0,0.0,2
101053,Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,48902400.0,0.0,2
101054,Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,48902400.0,0.0,2
101563,Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,24105600.0,0.0,2
101564,Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,24105600.0,0.0,2
103209,maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 09:00:00,0.0,9.0,0.0,9.0,950400.0,0.0,2
103210,maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 09:00:00,0.0,9.0,0.0,9.0,950400.0,0.0,2
106022,Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-20 09:00:00,0.0,9.0,2.0,9.0,45532800.0,0.0,2
106023,Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-20 09:00:00,0.0,9.0,2.0,9.0,45532800.0,0.0,2
80970,maligniteit cervix,TC61,DC106,SC61,other,34.0,640_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-09-21 09:00:00,273600.0,9.0,3.0,9.0,0.0,16416000.0,2
106791,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 09:00:00,0.0,9.0,3.0,9.0,45100800.0,0.0,2
106792,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830_2,AC372439,SLVE,Section 4,SC86,Special lab radiology,1.0,2006-09-28 09:00:00,0.0,9.0,3.0,9.0,45100800.0,0.0,2
108001,Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-27 09:00:00,0.0,10.0,4.0,9.0,43804800.0,0.0,2
108002,Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-27 09:00:00,0.0,10.0,4.0,9.0,43804800.0,0.0,2
72192,maligniteit cervix,TC101,M13,SC7,other,61.0,566_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-30 09:00:00,0.0,10.0,0.0,9.0,26265600.0,24537600.0,2
108730,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,37756800.0,0.0,2
108731,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846_2,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,37756800.0,0.0,2
108795,Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847_2,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,7257600.0,0.0,2
108796,Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,7257600.0,0.0,2
109637,Gynaecologische tumoren,TC61,DC106,SC7,other,76.0,849_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-08 09:00:00,0.0,11.0,2.0,9.0,12528000.0,0.0,2
109638,Gynaecologische tumoren,TC61,DC106,SC7,other,76.0,849_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-08 09:00:00,0.0,11.0,2.0,9.0,12528000.0,0.0,2
109718,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 09:00:00,0.0,11.0,2.0,9.0,7948800.0,0.0,2
109719,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 09:00:00,0.0,11.0,2.0,9.0,7948800.0,0.0,2
109969,Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-13 09:00:00,0.0,11.0,0.0,9.0,36979200.0,0.0,2
109970,Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-13 09:00:00,0.0,11.0,0.0,9.0,36979200.0,0.0,2
110045,Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853_2,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 09:00:00,0.0,11.0,2.0,9.0,33782400.0,0.0,2
110046,Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 09:00:00,0.0,11.0,2.0,9.0,33782400.0,0.0,2
111553,Adenoca: corpus uteri st IIIa,TC101,M14,SC7,other,76.0,859_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,2
111554,Adenoca: corpus uteri st IIIa,TC101,M14,SC7,other,76.0,859_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,2
111555,Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860_2,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,2
111556,Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-29 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,2
111595,maligniteit cervix,TC101,M13,SC7,DTC613784,59.0,861_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,38102400.0,0.0,2
111596,maligniteit cervix,TC101,M13,SC7,DTC613784,59.0,861_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,38102400.0,0.0,2
111805,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,35078400.0,0.0,2
111806,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,35078400.0,0.0,2
112042,Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866_2,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 09:00:00,0.0,12.0,2.0,9.0,5875200.0,0.0,2
112043,Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866_2,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 09:00:00,0.0,12.0,2.0,9.0,5875200.0,0.0,2
112072,Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867_2,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,1209600.0,0.0,2
112073,Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,1209600.0,0.0,2
112299,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 09:00:00,0.0,12.0,4.0,9.0,18576000.0,0.0,2
112300,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870_2,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 09:00:00,0.0,12.0,4.0,9.0,18576000.0,0.0,2
112750,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873_2,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 09:00:00,0.0,12.0,2.0,9.0,2505600.0,0.0,2
112751,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 09:00:00,0.0,12.0,2.0,9.0,2505600.0,0.0,2
113254,maligniteit ovarium | tuba,TC101,M16,SC7,other,82.0,878_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-20 09:00:00,0.0,12.0,2.0,9.0,0.0,0.0,2
113255,maligniteit ovarium | tuba,TC101,M16,SC7,other,82.0,878_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-20 09:00:00,0.0,12.0,2.0,9.0,0.0,0.0,2
113291,Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-21 09:00:00,0.0,12.0,3.0,9.0,36892800.0,0.0,2
113292,Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879_2,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-21 09:00:00,0.0,12.0,3.0,9.0,36892800.0,0.0,2
114701,Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886_2,AC610001,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-15 09:00:00,0.0,1.0,0.0,9.0,31017600.0,0.0,2
114702,Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886_2,AC613000,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-15 09:00:00,0.0,1.0,0.0,9.0,31017600.0,0.0,2
115036,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889_2,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2007-01-18 09:00:00,0.0,1.0,3.0,9.0,7948800.0,0.0,2
115037,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-18 09:00:00,0.0,1.0,3.0,9.0,7948800.0,0.0,2
115132,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-19 09:00:00,0.0,1.0,4.0,9.0,34732800.0,0.0,2
115133,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890_2,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2007-01-19 09:00:00,0.0,1.0,4.0,9.0,34732800.0,0.0,2
115444,Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 09:00:00,0.0,1.0,0.0,9.0,23328000.0,0.0,2
115445,Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891_2,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 09:00:00,0.0,1.0,0.0,9.0,23328000.0,0.0,2
116436,Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 09:00:00,0.0,1.0,1.0,9.0,24883200.0,0.0,2
116437,Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 09:00:00,0.0,1.0,1.0,9.0,24883200.0,0.0,2
117114,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 09:00:00,0.0,2.0,0.0,9.0,31622400.0,0.0,2
117115,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897_2,AC370606,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 09:00:00,0.0,2.0,0.0,9.0,31622400.0,0.0,2
117147,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898_2,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-07 09:00:00,0.0,2.0,2.0,9.0,86400.0,0.0,2
117148,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898_2,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-07 09:00:00,0.0,2.0,2.0,9.0,86400.0,0.0,2
117603,Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901_2,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-02-14 09:00:00,0.0,2.0,2.0,9.0,4838400.0,0.0,2
117604,Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901_2,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-14 09:00:00,0.0,2.0,2.0,9.0,4838400.0,0.0,2
117763,Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904_2,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 09:00:00,0.0,2.0,3.0,9.0,10800000.0,0.0,2
117764,Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904_2,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 09:00:00,0.0,2.0,3.0,9.0,10800000.0,0.0,2
117905,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906_2,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 09:00:00,0.0,2.0,3.0,9.0,6652800.0,0.0,2
117906,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906_2,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 09:00:00,0.0,2.0,3.0,9.0,6652800.0,0.0,2
95452,maligniteit cervix,TC101,M13,SC7,other,41.0,769_2,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-07-04 09:00:00,0.0,7.0,2.0,9.0,0.0,30844800.0,2
